Baxalta Announces FDA Approval of ADYNOVATE Treatment for Hemophilia A
November 14, 2015 at 08:08 AM EST
Baxalta Incorporated (NYSE: BXLT) announced Friday that the U.S. Food and Drug Administration (FDA) has approved ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.